Nervous System News and Research

Latest Nervous System News and Research

Sympathetic nervous system implicated in acupuncture analgesia

Acupuncture appears to activate the sympathetic nervous system in people experiencing pain, a randomized study indicates.

6 Feb 2013

Study findings suggest physical and pharmacological solutions for human stroke victims

Johns Hopkins researchers have found that mice can recover from physically debilitating strokes that damage the primary motor cortex, the region of the brain that controls most movement in the body, if the rodents are quickly subjected to physical conditioning that rapidly "rewires" a different part of the brain to take over lost function.

6 Feb 2013

Survivors of CNS cancer in childhood are at increased risk for disturbance in body image

Survivors of cancer of the central nervous system (CNS) in childhood are at heightened risk for disturbance in body image and self-image in relation to sports or other physical activities, according to a nationwide study from Karolinska Institutet in Sweden published in the Journal of Neuro-Oncology.

5 Feb 2013

DCC receptor plays key role in regulating brain plasticity

Our ability to learn and form new memories is fully dependent on the brain's ability to be plastic - that is to change and adapt according to new experiences and environments. A new study from the Montreal Neurological Institute - The Neuro, McGill University, reveals that DCC, the receptor for a crucial protein in the nervous system known as netrin, plays a key role in regulating the plasticity of nerve cell connections in the brain.

5 Feb 2013

Orphan, St George's sign licensing agreement to develop new therapies for metabolic disorders

St George's, University of London has signed an exclusive worldwide licensing agreement with rare-disease research-and-development firm Orphan Technologies Ltd to develop new therapies for deadly metabolic disorders.

5 Feb 2013

Patients with MS more likely to develop MI and stroke, regardless of migration background

A new study from Karolinska Institutet in Sweden shows that patients with multiple sclerosis (MS) run a high risk of heart attack, stroke and heart failure, regardless of migration background. According to Dr Tahereh Moradi, principal investigator, the study is the first in the world to examine the risk of cardiovascular diseases in male and female MS patients with both non-immigrant and immigrant backgrounds.

5 Feb 2013

Cause of esodeviation differs in children, adults

Children who present with acute-onset esodeviation should be investigated for underlying central nervous system disorders, study findings indicate.

4 Feb 2013

NFL funds WSU research to fix injured brains with new nerve cells

The National Football League thinks enough of the work that its charitable arm has given Krzysztof Czaja (pronounced K-shish-toff Chai-uh), a Washington State University neuroscientist, $100,000 to keep looking.

4 Feb 2013

Potential connection between autism and insulin-like growth factor

A New York-based physician-researcher from Touro College of Osteopathic Medicine, best known for his research into fertility and twinning, has uncovered a potential connection between autism and a specific growth protein that could eventually be used as a way to predict an infant's propensity to later develop the disease.

2 Feb 2013

Neural stem cell transplantation shows promise against gastrointestinal motility disorders

Proper function of the digestive system requires coordinated contraction of the muscle in the wall of the intestinal tract, regulated by the enteric nervous system.

2 Feb 2013

Top-line results from Vanda's tasimelteon Phase IIb/III study on major depressive disorder

Vanda Pharmaceuticals Inc. today announced top-line results of the Phase IIb/III clinical study (MAGELLAN) in Major Depressive Disorder (MDD), investigating the efficacy and safety of tasimelteon as a monotherapy in the treatment of patients with MDD.

31 Jan 2013

Biomaterials as neural stem cell niches can help repair damage in the CNS

Despite recent advances in understanding the mechanisms of nerve injury, tissue-engineering solutions for repairing damage in the central nervous system (CNS) remain elusive, owing to the crucial and complex role played by the neural stem cell (NSC) niche. This zone, in which stem cells are retained after embryonic development for the production of new cells, exerts a tight control over many crucial tasks such as growth promotion and the recreation of essential biochemical and physical cues for neural cell differentiation.

30 Jan 2013

Androgens could constitute an efficient treatment against multiple sclerosis

Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study by researchers from the Laboratoire d'Imagerie et de Neurosciences Cognitives, in collaboration in particular with the "Neuroprotection et Neurorégénération: Molécules Neuroactives de Petite Taille" unit.

30 Jan 2013

Apolipoprotein E-4 useful in promoting neuron growth in the lab

A protein associated with neuron damage in people with Alzheimer's disease is surprisingly useful in promoting neuron growth in the lab, according to a new study by engineering researchers at Brown University.

30 Jan 2013

Consuming carotenoid-rich foods may help prevent or delay onset of amyotrophic lateral sclerosis

New research suggests that increased consumption of foods containing colorful carotenoids, particularly beta-carotene and lutein, may prevent or delay the onset of amyotrophic lateral sclerosis (ALS).

29 Jan 2013

EC announces selection of Human Brain Project as one of its two FET Flagship program

The European Commission has officially announced the selection of the Human Brain Project (HBP) as one of its two FET Flagship projects. The new project will federate European efforts to address one of the greatest challenges of modern science: understanding the human brain.

29 Jan 2013

Millennium, Seattle Genetics commence ADCETRIS plus chemotherapy phase III trial in MTCL

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.

28 Jan 2013

HSS involving resiniferatoxin receives U.S. patent to alleviate intractable pain

The U. S. Patent and Trademark Office recently issued a patent to the U. S. Department of Health and Human Services involving resiniferatoxin, or RTX, an experimental compound that represents a potential new class of drugs to alleviate the intractable pain that can occur in people with advanced cancer, severe arthritis, and other extremely chronic conditions.

28 Jan 2013

FDA accepts Genzyme’s LEMTRADA sBLA for review

Genzyme, a Sanofi Company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's supplemental Biologics License Application (sBLA) file seeking approval of LEMTRADA (alemtuzumab) for the treatment of relapsing multiple sclerosis (RMS).

28 Jan 2013

Intravenous iron dextran effective for restless leg syndrome

Intravenous low molecular weight iron dextran appears to provide effective long-lasting treatment for some patients with restless leg syndrome, even for those with normal serum ferritin levels, research indicates.

25 Jan 2013

Nervous System News and Research

Latest Nervous System News and Research

Sympathetic nervous system implicated in acupuncture analgesia

Study findings suggest physical and pharmacological solutions for human stroke victims

Survivors of CNS cancer in childhood are at increased risk for disturbance in body image

DCC receptor plays key role in regulating brain plasticity

Orphan, St George's sign licensing agreement to develop new therapies for metabolic disorders

Patients with MS more likely to develop MI and stroke, regardless of migration background

Cause of esodeviation differs in children, adults

NFL funds WSU research to fix injured brains with new nerve cells

Potential connection between autism and insulin-like growth factor

Neural stem cell transplantation shows promise against gastrointestinal motility disorders

Top-line results from Vanda's tasimelteon Phase IIb/III study on major depressive disorder

Biomaterials as neural stem cell niches can help repair damage in the CNS

Androgens could constitute an efficient treatment against multiple sclerosis

Apolipoprotein E-4 useful in promoting neuron growth in the lab

Consuming carotenoid-rich foods may help prevent or delay onset of amyotrophic lateral sclerosis

EC announces selection of Human Brain Project as one of its two FET Flagship program

Millennium, Seattle Genetics commence ADCETRIS plus chemotherapy phase III trial in MTCL

HSS involving resiniferatoxin receives U.S. patent to alleviate intractable pain

FDA accepts Genzyme’s LEMTRADA sBLA for review

Intravenous iron dextran effective for restless leg syndrome

Everything you need to know about epilepsy eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Nervous System News and Research

Latest Nervous System News and Research

Everything you need to know about epilepsy eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in